15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English Hepatitis B Virus Replication Could Enhance Regulato ...
查看: 1179|回复: 0
go

Hepatitis B Virus Replication Could Enhance Regulatory T Cell Activity by [复制链接]

Rank: 1

现金
222032 元 
精华
285 
帖子
67620 
注册时间
2001-11-10 
最后登录
2023-5-7 

元帅勋章 功勋会员 小花 管理员或超版 荣誉之星 勤于助新 龙的传人 大财主勋章 白衣天使 旺旺勋章 心爱宝宝 携手同心 驴版 有声有色 东北版 美食大使 幸福四叶草 翡翠丝带 健康之翼 幸福风车 恭喜发财 人中之龙

1
发表于 2010-6-20 15:09 |只看该作者 |倒序浏览 |打印
本帖最后由 风雨不动 于 2012-4-14 16:27 编辑

Producing Soluble Heat Shock Protein 60 From Hepatocytes

<http://www.journals.uchicago.edu/doi/abs/10.1086/653496>

The Journal of Infectious Diseases 2010;202:202–213
© 2010 by the Infectious Diseases Society of America. All rights reserved.
0022-1899/2010/20202-0004$15.00
DOI: 10.1086/653496

MAJOR ARTICLE
Hepatitis B Virus Replication Could Enhance Regulatory T Cell Activity by
Producing Soluble Heat Shock Protein 60 From Hepatocytes

Yasuteru Kondo,1
Yoshiyuki Ueno,1
Koju Kobayashi,2
Eiji Kakazu,1
Masaaki Shiina,1
Jun Inoue,1
Keiichi Tamai,1
Yuta Wakui,1
Yasuhito Tanaka,5
Masashi Ninomiya,1
Noriyuki Obara,1
Koji Fukushima,1
Motoyasu Ishii,3
Tomoo Kobayashi,4
Hirofumi Niitsuma,1
Satonori Kon,2 and
Tooru Shimosegawa1
1Division of Gastroenterology, Tohoku University Hospital, 2School of Health
Science, Tohoku University, 3Department of Gastroenterology, Miyagi Social
Insurance Hospital, and 4Department of Gastroenterology, Tohoku Rosai
Hospital, Sendai, and 5Clinical Molecular Informative Medicine, Nagoya City
University, Nagoya, Japan


Background.HBcAg‐specific regulatory T (Treg) cells play an important role
in the pathogenesis of chronic hepatitis B. Soluble heat shock proteins,
especially soluble heat shock protein 60 (sHSP60), could affect the function
of Treg cells via Toll‐like receptor.

Methods.We analyzed the relationship between soluble heat shock protein
production and hepatitis B virus (HBV) replication with both clinical samples
from HBeAg‐positive patients with chronic hepatitis B ( ) and
HBeAb‐positive patients with chronic hepatitis B ( ) and in vitro
HBV‐replicating hepatocytes. Thereafter, we examined the biological effects
of sHSP60 with isolated Treg cells.

Results.The serum levels of sHSP60 in patients with chronic hepatitis B were
statistically significantly higher than those in patients with chronic
hepatitis C ( ), and the levels of sHSP60 were correlated with the HBV DNA
levels ( ;  ) but not with the alanine aminotransferase levels. Moreover, the
levels of sHSP60 in HBV‐replicating HepG2 cells were statistically
significantly higher than those in control HepG2 cells. Preincubation of CD4+
CD25+ cells with recombinant HSP60 (1 ng/mL) statistically significantly
increased the frequency of HBcAg‐specific interleukin 10–secreting Treg
cells. The frequency of IL7R−CD4+CD25+ cells, the expression of Toll‐like
receptor 2, and the suppressive function of Treg cells had declined during
entecavir treatment.

Conclusion.The function of HBcAg‐specific Treg cells was enhanced by sHSP60
produced from HBV‐infected hepatocytes. Entecavir treatment suppressed the
frequency and function of Treg cells; this might contribute to the persistence
of HBV infection.


Received 14 July 2009; accepted 3 February 2010; electronically published 9
June 2010.

Reprints or correspondence: Yoshiyuki Ueno, Division of Gastroenterology,
Tohoku University Graduate School of Medicine, Seiryo 1‐1, Aobaku, Sendai,
980‐8574, Japan ([email protected]).

Potential conflicts of interest: none reported.

Financial support: Ministry of Health, Labor, and Welfare of Japan (Health and
Labor Sciences Research Grants for the Research on Measures for Intractable
Diseases); Ministry of Education, Culture, Sports, Science, and Technology of
Japan (grant 21790642 to Y.K.).



(6.合.彩).足球.篮球...各类投注开户下注

第一投注.现金网:招代理年薪10万以上:6668.cc
已有 1 人评分现金 收起 理由
IC + 1 精品文章

总评分: 现金 + 1   查看全部评分

‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-15 12:22 , Processed in 0.015456 second(s), 12 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.